The GeneXpert diagnostic testing technology from the US corporation Cepheid, and its parent company Danaher, has revolutionised rapid, accurate diagnosis of tuberculosis (TB) and other diseases, since entering the market in 2010. Yet, due to the high cost of the GeneXpert test cartridges, many countries are not able to scale up testing for all people who need lifesaving diagnosis and subsequent treatment.
Diabetes type I affects children and adolescents, who often find difficulties adapting to this lifelong chronic disease. Here are some of the stories of brave children with diabetes we meet in our clinics.
Across sub-Saharan Africa, many children and adults diagnosed with diabetes cannot afford to manage their disease and many are simply dying before being diagnosed.
A combination of generic drugs coupled with a comprehensive patient support model has shown promising results in a pilot project run by Médecins Sans Frontières (MSF) in Ukraine.
Antibiotic resistance (ABR) is a major health issue and can affect anyone, of any age, anywhere. It is caused by the overuse or misuse of antibiotics. Antibiotic resistance (ABR) is a looming challenge for MSF’s work around the world ...
It’s that time of year when we pause for a moment from the daily routine to make our wishes for the upcoming new year! We look forward to grasping the new opportunities the year will bring to make breakthroughs in ensuring affordable ...